Diphenoxylate Hydrochloride And Atropine Sulfate
Product Images NDC 66336-437

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diphenoxylate Hydrochloride And Atropine Sulfate (NDC 66336-437). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 66336-0437-xx (Ndc 66336 0437 Xx Mylan)

Ndc 66336-0437-xx (Ndc 66336 0437 Xx        Mylan)
This text seems to describe a medicine produced by Mylan Pharmaceuticals. The medicine is in a white, round tablet form with the marking "M 15". The medicine should be dispensed in a container that is tight and resistant to light. The prescription is cautionary to federal law to prevent drug abuse. The medicine may cause drowsiness and should not be consumed with alcoholic beverages. The medicine contains DIPHENOXYLATE HCI/ATROPINE SULFATE 2.5mg/0.025 mg tablets with lot # SAMPLE EXP: 00-00. There is also information about dispensing and storing this medicine.*
FDA Label Image

Diphenoxylate Hydrochloride Structural Formula (E3ab45aa 9ef1 4353 Ab1b 862f969ec479 01)

FDA Label Image

Atropine Structural Formula (E3ab45aa 9ef1 4353 Ab1b 862f969ec479 02)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.